Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy

NCT00630149 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: Pemetrexed (Alimta)

Sponsor

Sun Yat-sen University

Collaborators

[object Object]